GGrantIndex
Sort

40,608 grants matching prostate cancer

Mutations and Target Genes in Adenoid Cystic Carcinoma

$359,813
Scott A. Ness · University Of New Mexico Health Scis Ctr · R01 · FY2020 · DE

Mutations and Target Genes in Adenoid Cystic Carcinoma

$359,813
Scott A. Ness · University Of New Mexico Health Scis Ctr · R01 · FY2019 · DE

Mutations and Target Genes in Adenoid Cystic Carcinoma

$359,813
Scott A. Ness · University Of New Mexico Health Scis Ctr · R01 · FY2021 · DE

Dietary Patterns, Diet Quality + Cancer Risk

$359,781
Frank B Hu · Harvard School Of Public Health · R01 · FY2008 · CA

Project 1- Role of fat in metastatic engraftment and expansion in the liver

$359,780
Neil A Bhowmick · Cedars-Sinai Medical Center · P01 · FY2023 · CA

Adenovirus Replication-Competent Anti-Cancer Vector

$359,756
Virrx, Inc · R42 · FY2003 · CA

Quantitative Analysis of Epidermal Growth Factor Receptor Signaling Networks

$359,707
Forest M White · Massachusetts Institute Of Technology · R01 · FY2011 · CA

Neural Mechanisms of Cancer Pain

$359,693
Donald A Simone · University Of Minnesota · R01 · FY2023 · CA

Function of TbRIII as a BMP Co-receptor in Human Cancer

$359,685
Gerard C Blobe · Duke University · R01 · FY2009 · CA

18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma

$359,596
David Michael Schuster · Emory University · R01 · FY2008 · CA

Studies of Non-Ionizing Radiation-Related Cancer

$359,570
Elizabeth Cahoon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA

Pattern recognition in medical imaging

$359,544
Ilya Goldberg · National Institute On Aging · ZIC · FY2009 · AG

Nanoparticle-Based Triple Modality Imaging and Photothermal Therapy of Brain Tumors

$359,542
Sanjiv S Gambhir · Stanford University · R01 · FY2017 · CA

Molecular mechanisms specific to ETS transcription factors that drive oncogenesis

$359,523
Peter Celestine Hollenhorst · Indiana University Indianapolis · R01 · FY2017 · CA

Nanoparticle-Based Triple Modality Imaging and Photothermal Therapy of Brain Tumors

$359,516
Sanjiv S Gambhir · Stanford University · R01 · FY2016 · CA

Technology Diffusion in Cancer: Geographic Variations, Facilitators, Outcomes, and Costs

$359,485
Ya-Chen Tina Shih · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL

$359,476
Izidore S Lossos · University Of Miami School Of Medicine · R01 · FY2021 · CA

Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL

$359,476
Izidore S Lossos · University Of Miami School Of Medicine · R01 · FY2019 · CA

Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL

$359,476
Izidore S Lossos · University Of Miami School Of Medicine · R01 · FY2020 · CA

Studies of the Antifungal Drug Itraconazole As A Novel Inhibitor of Angiogenesis

$359,457
Jun O. Liu · Johns Hopkins University · R01 · FY2019 · CA

Development of small molecules for ERG ablation in prostate cancer

$359,457
Ralf Kittler · Ut Southwestern Medical Center · R01 · FY2019 · CA

MRI-Based Radiation Therapy Treatment Planning

$359,444
Ruijiang Li · Stanford University · R01 · FY2017 · CA

Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function

$359,321
Earl Howard Harrison · Ohio State University · R01 · FY2013 · HL

Tracking Urogenital Sinus Cell Progeny

$359,270
University Of Delaware · R01 · FY2002 · DK

GSTP1 Promoter Hypermethylation In Human Prostate Cancer

$359,231
William George Nelson · Johns Hopkins University · R01 · FY2006 · CA